Canadian Online Pharmacy

CDER New July 3, 2012

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

July 2, 2012


New and Generic Drug Approvals

June 29, 2012

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Cosyntropin cosyntropin Injectable; Injection Innopharma Inc Approval
Glimepiride glimepiride Tablet; Oral Micro Labs Usa Approval
Glimepiride glimepiride Tablet; Oral Aurobindo Pharma Ltd Approval
Guanfacine Hydrochloride guanfacine hydrochloride Tablet, Extended Release; Oral Actavis Elizabeth Tentative Approval
Hydrocodone Polistirex and Chlorpheniramne Polistirex chlorpheniramine polistirex; hydrocodone polistirex Suspension, Extended Release; Oral Cornerstone Therap Approval
Levocetirizine Dihydrochloride levocetirizine dihydrochloride Tablet; Oral Hetero Labs Ltd Iii Approval
Lithium Carbonate lithium carbonate Tablet, Extended Release; Oral Mylan Pharms Inc Approval
Lopinavir; Ritonavir lopinavir; ritonavir Solution; Oral Cipla Limited Tentative Approval
Promethazine Hydrochloride and Codeine Phosphate codeine phosphate; promethazine hydrochloride Syrup; Oral Tris Pharma Inc Approval

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery